Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symphonix Devices was a medical technology company that developed and commercialized implantable hearing solutions, most notably the Vibrant Soundbridge. As the first FDA-approved semi-implantable middle ear hearing system, the Vibrant Soundbridge provided a treatment option for adults with moderate-to-severe sensorineural hearing loss who were dissatisfied with traditional hearing aids. The company's technology utilized a unique electromagnetic transducer to directly vibrate the middle ear bones, bypassing the ear canal and tympanic membrane. Despite its clinical success and regulatory milestones, the company encountered financial difficulties and was eventually acquired by Med-El in 2003. Today, the technology remains a cornerstone of Med-El's middle ear implant portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symphonix.